Effects on Appetite

• General Context: The role of cannabis in regulating appetite is significant and well-researched, moving beyond just anecdotal experiences. Many people know the feeling of increased hunger after consuming cannabis, often referred to as "the munchies," but this effect has scientific backing.

• The Milkshake Study: In a study published in a scientific journal, researchers found that when patients were given THC (Tetrahydrocannabinol), which is the main psychoactive compound in cannabis, they consumed more milkshakes than those who did not receive THC. This supports the idea that cannabis can enhance appetite.

• Cross-talk in the Reward System: - Certain cannabis compounds, particularly CB1 agonists like THC, activate the brain's reward system.

  • When people eat tasty foods, especially those high in sugars and fats, their brain also releases reward signals.

  • THC works by utilizing the endocannabinoid system, which increases the desire for and pleasure derived from consuming food, giving us inherent pleasure when we eat.

The Role of Leptin and Adipose Tissue

• Definition of Leptin: Leptin is a hormone produced by fat cells (adipose tissue) that helps regulate energy balance by telling the brain to decrease appetite when enough energy has been consumed.

• Source of Secretion: This hormone is secreted by adipose tissue, meaning that the more fat cells we have, the more leptin is released into our bloodstream.

• Homeostatic Function: Normally, when our body has more adipose tissue, it secretes more leptin, signaling the brain to reduce hunger. This is a vital mechanism for maintaining energy balance and preventing overeating.

• Interaction with THC: Interestingly, THC from cannabis can lower the levels of leptin. This means that it can effectively shut down this biological signal that normally tells our bodies to stop eating, leading to increased appetite instead.

Therapeutic Applications: Cachexia and Muscle Wasting

• Definition of Cachexia: Cachexia is a severe condition characterized by significant muscle loss and weight loss, typically seen in patients who cannot intake enough calories to maintain their body mass.

• Prevalence in Disease: - Cancer: Many cancer patients experience cachexia, which may stem from both the disease itself and the side effects of cancer treatments like chemotherapy.

  • AIDS and Anorexia: Other conditions such as AIDS and anorexia can lead to drastic weight loss and reduced appetite, further linking to cachexia.     

• Mechanism of Mortality in Cancer: Unlike many diseases where death is caused directly through organ failure, in cancer, cachexia can be a major cause of death. Weakening of muscles, including the diaphragm (a crucial muscle for breathing), can lead to respiratory failure.
      

• THC as a Treatment: Cannabis, particularly THC, can help increase appetite and body weight in cachectic people, although the results of such treatments can vary. One reason for these mixed results is that just because a patient eats more doesn't mean they will gain muscle mass. There may be other complex biological factors at play that we don’t fully understand yet.

FAAH Inhibitors and Targeted Endocannabinoids

• FAAH Definition: Fatty Acid Amide Hydrolase (FAAH) is an enzyme that breaks down Anandamide (AEA), an endocannabinoid that naturally occurs in the body and plays a role similar to THC.

• Effect of Inhibition: When we inhibit FAAH, the levels of AEA in our body rise.

• Experimental Findings: Studies in animals suggest that inhibiting FAAH can lead to increased body mass, indicating potential for treatments involving this pathway.

• Advantages of FAAH Inhibition vs. Exogenous THC: - Targeted Effect: Increasing AEA levels through FAAH inhibition can be more effective and safer because it targets the body’s natural pathways without introducing THC into parts of the brain that might not need it.
  

  • Reduced Side Effects: By avoiding the introduction of external cannabinoids like THC, which can cause unwanted side effects such as impairment in cognitive function, we might find a safer way to stimulate appetite.

Detailed Hormonal Regulation of Appetite

• The Tug of War: There’s a constant balancing act between leptin and the endocannabinoid system, which affects two important hormones: Melanocortin and Neuropeptide Y.

  • Melanocortin: This hormone has the role of decreasing appetite.

  • Neuropeptide Y: Conversely, this hormone increases appetite.     

• Regulatory Pathways: - Leptin's Goal: Leptin aims to increase Melanocortin levels and decrease Neuropeptide Y levels, which results in lowered appetite.

  • Endocannabinoids' Goal: The endocannabinoid system aims to do the opposite: increase Neuropeptide Y while decreasing Melanocortin, which leads to increased appetite.

  • Reciprocal Inhibition: When endocannabinoid levels rise, leptin’s production and effectiveness can be reduced. This highlights a complex relationship where increased appetite from cannabis or natural processes can inhibit the body's ability to signal fullness.

• Cholecystokinin (CCK): - CCK is another hormone involved in making us feel full. It is secreted in the intestine when we eat.

  • When there is a lot of fat or food in the gut, CCK signals the brain to stop eating.

  • Mechanism: CCK reduces the expression of CB1 receptors, meaning it can also help suppress appetite by decreasing the effects of endocannabinoids.

• Ghrelin: - This is often called the “hunger hormone” because it is produced in the stomach when it is empty.

  • Instead of triggering appetite suppression, ghrelin stimulates hunger and keeps the endocannabinoid system active.

  • THC Connection: THC has been shown to increase ghrelin levels, which is one way it boosts appetite.

Homeostatic vs. Hedonistic Eating

• Homeostatic Eating: This type of eating is driven by the body’s actual need for food. It occurs when we feel hungry and represents our body's way to maintain energy balance.

• Hedonistic Eating: This type of eating is more about pleasure. People consume food not necessarily because they are hungry but because they enjoy it, like indulging in chocolate or a beloved dessert when not physically hungry.

• Evolutionary Perspective: - Foods that are high in calories (like sweets and fatty foods) triggered a stronger positive response in the brain compared to less calorie-dense foods, like vegetables.

  • This evolutionary development is believed to have formed when food was scarce, encouraging behaviors that rewarded high-calorie food consumption to ensure survival.

• Negative Feedback Loop: - After consuming high-calorie, rewarding food, the body has a natural response to reduce the expression of CB1 receptors through negative feedback mechanisms. This essentially helps regulate appetite and prevents overeating.

  • Fasting vs. Eating: During times of fasting, levels of endocannabinoids rise to promote hunger. Once food is consumed, especially high-calorie foods, the body decreases endocannabinoid signaling to mitigate excessive eating.

Endocannabinoid Dysregulation and Obesity

• Clinical Correlation: Research shows that people with obesity quite often have issues with the endocannabinoid system regulation.

• Resistance Mechanisms: In cases of chronic overeating, this system's feedback mechanism can break down. For many obese individuals, there’s an overproduction of both endocannabinoids and CB1 receptors, enhancing the signals of hunger.

• Rimonabant (SR141716): - Rimonabant is a drug that blocks the CB1 receptors and was created as an anti-obesity medication.

  • Although it showed promising results in trials in Europe for weight reduction, it was never approved in the US.

  • Success: It was effective at helping people lose weight in clinical trials.

  • Failure/Withdrawal: The drug was pulled from the market due to severe psychiatric side effects such as increased anxiety and depression, highlighting the complexity of the endocannabinoid system, which is involved in various brain functions beyond just appetite regulation.

• Future Pharmaceutical Strategies:1. Peripheral Antagonists: Scientists are exploring creating drugs that do not cross the blood-brain barrier (BBB), ensuring they work on fat tissue without causing mental side effects.

  2. Endocannabinoid Production Modulation: Researchers seek ways to reduce the production of endocannabinoids, though this goal remains challenging.

  3. Allosteric Modulators: There’s interest in developing drugs that interact with the CB1 receptors in a different way than traditional agonists do. These drugs might reduce the signaling effects of existing endocannabinoids without fully blocking the receptors.

Roles of Other Cannabinoids in Appetite

• Tetrahydrocannabivarin (THCV): - THCV is another natural compound found in cannabis but functions differently than THC as it can act as a CB1 antagonist.

  • This means it could potentially reduce appetite rather than increase it, similar to Rimonabant in action. Even though it has this opposite effect, it may still cause the same mental health side effects, so exploration in using it as a weight loss treatment has not gained traction.

• Cannabinol (CBN): - CBN is a byproduct of the breakdown of THC.

  • CBN acts as a partial agonist, which means it doesn’t stimulate the receptors as strongly as THC.

  • Research Finding: Studies have demonstrated that CBN can increase feeding behavior in rats, suggesting it may help with appetite stimulation but might do so with fewer psychoactive effects compared to THC.

• Cannabidiol (CBD): - The role of CBD regarding appetite is still under investigation and hasn’t produced consistent results.

  • Some take CBD before meals and report that it might reduce overall food intake. However, it is not currently recognized as a reliable appetite suppressant for people who want to use it for weight control over the long term.